Sign up
Pharma Capital

LexaGene Holdings sees path to sales through multiple uses of technology

LexaGene Holdings (CVE:LXG) CEO and Co-Founder Dr. Jack Regan joined Steve Darling from the Toronto studio of Proactive to talk about their technology that is being used in multiple ways. From dogs to E-coli, Regan talked about how their machine can be a major help.

Regan also telling Proactive what the next year looks like for the company as they ramp up their sales teams and look at different sectors. 


View full LXG profile View Profile
View All

© biotech Capital 2019

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.